Friday, July 10, 2026

pharma · Hypertension · Gastric Ulcer

Yung Shin Pharmaceutical

Yung Shin Pharmaceutical trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Taichung, CN HQ
1952 Founded
264 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Taichung, CN
Founded
1952
Employees
264
Programs
10
Drugs
13
Patents
0
Intelligence · Clinical Trials

Yung Shin Pharmaceutical clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to Yung Shin Pharmaceutical programs — each row shows trial ID, program name, phase, status, and indication.

Yung Shin Pharmaceutical trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Yung Shin Pharmaceutical.

  1. Rabeprazole Sodium 10mg — Phase 1

    Clinical update
  2. Prednisone + Jakavi(ruxolitinib) — Phase 2

    Clinical update
  3. Fimasartan/Atorvastatin Combination Tablet — Phase 1

    Clinical update
  4. Fimasartan and Rosuvastatin — Phase 3

    Clinical update
  5. dabigatran — Phase 3

    Clinical update
  6. gemcitabine — Phase 2

    Clinical update
  7. BRI-1501 — Phase 1

    Clinical update
  8. Fimasartan — Phase 1

    Clinical update

Trial registry

10 studies